Found: 60
Select item for more details and to access through your institution.
Zolbetuximab Plus Chemotherapy Offers Survival Benefits in Treatment-Naive HER2- Gastric/GEJ Cancer.
- Published in:
- OncologyLive, 2024, v. 25, n. 14, p. 50
- By:
- Publication type:
- Article
Personalized Initiatives Empower Patients to Actively Participate in Cancer Research.
- Published in:
- OncologyLive, 2024, v. 25, n. 14, p. 48
- By:
- Publication type:
- Article
MAGEA4 Opens the Door for Engineered Cellular Therapies in Solid Tumors.
- Published in:
- OncologyLive, 2024, v. 25, n. 14, p. 31
- By:
- Publication type:
- Article
Gynecologic Cancer Paradigm Sees Huge Gains With FDA-Approved Regimens.
- Published in:
- OncologyLive, 2024, v. 25, n. 14, p. 16
- By:
- Publication type:
- Article
Production of greenhouse-grown biocrust mosses and associated cyanobacteria to rehabilitate dryland soil function.
- Published in:
- Restoration Ecology, 2016, v. 24, n. 3, p. 324, doi. 10.1111/rec.12311
- By:
- Publication type:
- Article
Material Characterisation and Stratification of Conjunctival Epithelial Cells on Electrospun Poly(ε-Caprolactone) Fibres Loaded with Decellularised Tissue Matrices.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 3, p. 318, doi. 10.3390/pharmaceutics13030318
- By:
- Publication type:
- Article
A Novel Approach to Cultivate Biocrusts for Restoration and Experimentation.
- Published in:
- Ecological Restoration, 2015, v. 33, n. 1, p. 13, doi. 10.3368/er.33.1.13
- By:
- Publication type:
- Article
Characterization of Tunable Poly‐ε‐Lysine‐Based Hydrogels for Corneal Tissue Engineering.
- Published in:
- Macromolecular Bioscience, 2021, v. 21, n. 7, p. 1, doi. 10.1002/mabi.202100036
- By:
- Publication type:
- Article
Development of Native Plant Materials for Restoration and Rehabilitation of Colorado Plateau Ecosystems.
- Published in:
- Natural Areas Journal, 2015, v. 35, n. 1, p. 134, doi. 10.3375/043.035.0117
- By:
- Publication type:
- Article
Moss establishment in restoration: The role of moss production method and short‐term benefits of abscisic acid.
- Published in:
- Land Degradation & Development, 2023, v. 34, n. 14, p. 4320, doi. 10.1002/ldr.4779
- By:
- Publication type:
- Article
Adapting mechanized vascular plant seed dispersal technologies to biocrust moss restoration.
- Published in:
- Restoration Ecology, 2020, v. 28, p. S25, doi. 10.1111/rec.12998
- By:
- Publication type:
- Article
A Multipronged Approach Can Address Disparities in Cancer Care for Patients in Rural Communities.
- Published in:
- OncologyLive, 2024, v. 25, n. 13, p. 47
- By:
- Publication type:
- Article
Immunotherapy Combinations Dominate Frontline Discussions in Advanced RCC.
- Published in:
- OncologyLive, 2024, v. 25, n. 13, p. 16
- By:
- Publication type:
- Article
ELEMENT-MDS May Broaden Luspatercept's Scope Into Non--Transfusion-Dependent Lower-Risk MDS.
- Published in:
- OncologyLive, 2024, v. 25, n. 12, p. 34
- By:
- Publication type:
- Article
TROP2 Offers Attractive Therapeutic Target in Breast Cancer and Other Solid Tumors.
- Published in:
- OncologyLive, 2024, v. 25, n. 12, p. 31
- By:
- Publication type:
- Article
Treatment Personalization Is Poised to Define New Era of mCRC Therapy.
- Published in:
- OncologyLive, 2024, v. 25, n. 12, p. 16
- By:
- Publication type:
- Article
Exploiting the Vulnerabilities of High-Grade Serous Ovarian Cancer Through WEE1 Inhibition.
- Published in:
- OncologyLive, 2024, v. 25, n. 8, p. 45
- By:
- Publication type:
- Article
Rezatapopt Takes Aim at Previously Untargetable TP53 Allele in Advanced Solid Tumors.
- Published in:
- OncologyLive, 2024, v. 25, n. 11, p. 40
- By:
- Publication type:
- Article
PARP1-Selective Inhibitors Generate Excitement in Solid Tumors.
- Published in:
- OncologyLive, 2024, v. 25, n. 11, p. 37
- By:
- Publication type:
- Article
HER2-Directed ADCs Spread Like Wildfire Across the Spectrum of Solid Malignancies.
- Published in:
- OncologyLive, 2024, v. 25, n. 11, p. 16
- By:
- Publication type:
- Article
Optimize Interventions to Get a Step Ahead of Financial Toxicity in Cancer Care.
- Published in:
- OncologyLive, 2024, v. 25, n. 10, p. 49
- By:
- Publication type:
- Article
RLY-2608 Uses PI3Kα Mutant-- Specific Inhibition to More Safely Treat Breast Cancer and Other Solid Tumors.
- Published in:
- OncologyLive, 2024, v. 25, n. 10, p. 38
- By:
- Publication type:
- Article
Immune Therapy, EGFR Inhibition Take Hold of Stage III NSCLC.
- Published in:
- OncologyLive, 2024, v. 25, n. 10, p. 22
- By:
- Publication type:
- Article
DESTINY-Breast03 and DESTINY-Breast06 Data Shape Metastatic Breast Cancer Treatment.
- Published in:
- OncologyLive, 2024, v. 25, n. 9, p. 62
- By:
- Publication type:
- Article
Ostensibly Improves Cancer Care but Carries Unforeseen Consequences.
- Published in:
- OncologyLive, 2024, v. 25, n. 9, p. 58
- By:
- Publication type:
- Article
RAMP 301 Aims to Solidify Avutometinib Plus Defactinib in Recurrent LGSOC.
- Published in:
- OncologyLive, 2024, v. 25, n. 9, p. 50
- By:
- Publication type:
- Article
New Data Augment the Treatment Paradigm in HR+/HER2- Breast Cancer.
- Published in:
- OncologyLive, 2024, v. 25, n. 9, p. 24
- By:
- Publication type:
- Article
ADCs and TKIs Look to Carve Out Their Place in the HER2-Mutant NSCLC Treatment Paradigm.
- Published in:
- OncologyLive, 2024, v. 25, n. 8, p. 22
- By:
- Publication type:
- Article
Advances in MRD Testing Help Guide Optimal Colorectal Cancer Therapy.
- Published in:
- OncologyLive, 2024, v. 25, n. 7, p. 24
- By:
- Publication type:
- Article
Leveraging Managed Service Organizations to Provide More Affordable, Personalized Cancer Care.
- Published in:
- OncologyLive, 2024, v. 25, n. 7, p. 60
- By:
- Publication type:
- Article
Tiragolumab/Atezolizumab and Chemo Offers Survival Benefit Over Chemo Alone in ESCC.
- Published in:
- OncologyLive, 2024, v. 25, n. 4, p. 57
- By:
- Publication type:
- Article
DENALI Study Seeks to Prove Efficacy of Azenosertib in High-Grade Serous Ovarian Cancer.
- Published in:
- OncologyLive, 2024, v. 25, n. 7, p. 50
- By:
- Publication type:
- Article
Emavusertib Progresses to Phase 2 Study in AML and MDS.
- Published in:
- OncologyLive, 2024, v. 25, n. 6, p. 34
- By:
- Publication type:
- Article
Immunotherapy-Based Approaches Make Waves in Bladder Cancer.
- Published in:
- OncologyLive, 2024, v. 25, n. 6, p. 16
- By:
- Publication type:
- Article
FAK Inhibition Emerges as a Potential Complementary Treatment Pathway.
- Published in:
- OncologyLive, 2024, v. 25, n. 6, p. 31
- By:
- Publication type:
- Article
Patient Insurance Status and Out-of-Pocket Costs Affect Genomic Testing Frequency.
- Published in:
- OncologyLive, 2024, v. 25, n. 5, p. 42
- By:
- Publication type:
- Article
Despite FDA’s Call for Secondary Malignancies Boxed Warning on CAR T-Cell Agents, Questions Linger.
- Published in:
- OncologyLive, 2024, v. 25, n. 5, p. 24
- By:
- Publication type:
- Article
ASCO GI Updates Provide Window Into Evolving HCC Treatment Paradigm.
- Published in:
- OncologyLive, 2024, v. 25, n. 5, p. 16
- By:
- Publication type:
- Article
APEX-01 Looks to Add First PSMA-Directed ADC to Treatment Paradigm in mCRPC.
- Published in:
- OncologyLive, 2024, v. 25, n. 4, p. 32
- By:
- Publication type:
- Article
PRAME Shows Promise as a Treatment Avenue in Melanoma, Other Solid Tumors.
- Published in:
- OncologyLive, 2024, v. 25, n. 4, p. 30
- By:
- Publication type:
- Article
Data From 2023 ASH Annual Meeting Provide Positive Updates in Multiple Myeloma.
- Published in:
- OncologyLive, 2024, v. 25, n. 4, p. 17
- By:
- Publication type:
- Article
Gynecologic Oncologists Explore Treatment Options in LGSOC, Look Toward Promising Future.
- Published in:
- OncologyLive, 2024, v. 25, n. 3, p. 59
- By:
- Publication type:
- Article
Early-Phase Clinical Research Center Poised to Provide New Benefits in Hawaii and Beyond.
- Published in:
- OncologyLive, 2024, v. 25, n. 3, p. 48
- By:
- Publication type:
- Article
Frontline Camrelizumab/ Rivoceranib Combination Shows Promise in Unresectable HCC.
- Published in:
- OncologyLive, 2024, v. 25, n. 3, p. 44
- By:
- Publication type:
- Article
SABCS 2023 Findings Build on Positive Momentum in HER2+ Breast Cancer.
- Published in:
- OncologyLive, 2024, v. 25, n. 3, p. 24
- By:
- Publication type:
- Article
Insolation and disturbance history drive biocrust biodiversity in Western Montana rangelands.
- Published in:
- Plant & Soil, 2018, v. 430, n. 1/2, p. 151, doi. 10.1007/s11104-018-3725-3
- By:
- Publication type:
- Article
Biocrust moss populations differ in growth rates, stress response, and microbial associates.
- Published in:
- Plant & Soil, 2018, v. 429, n. 1/2, p. 187, doi. 10.1007/s11104-017-3389-4
- By:
- Publication type:
- Article
Matching seed to site by climate similarity: Techniques to prioritize plant materials development and use in restoration.
- Published in:
- Ecological Applications, 2017, v. 27, n. 3, p. 1010, doi. 10.1002/eap.1505
- By:
- Publication type:
- Article
Biomaterials for Regenerative Medicine Approaches for the Anterior Segment of the Eye.
- Published in:
- Advanced Healthcare Materials, 2018, v. 7, n. 10, p. 1, doi. 10.1002/adhm.201701328
- By:
- Publication type:
- Article
Fine-scale trait variation of five native forbs along environmental gradients.
- Published in:
- Native Plants Journal (University of Wisconsin Press), 2023, v. 24, n. 3, p. 192, doi. 10.3368/npj.24.3.192
- By:
- Publication type:
- Article